MimeCure
PrivateLast Round
Debt
Jan 1, 2026
Total Funding Raised
$220,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
MimeCure operates in Cybersecurity and is based in Eelde. Its latest recorded funding round was a Grant round in December 2025.
MimeCure is a biotechnology company developing a first-in-class regenerative therapy for chronic and progressive lung diseases, with an initial focus on idiopathic pulmonary fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD).
Sector
Cybersecurity
Verticals
Email Security, Data Protection, Cloud Security, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MimeCure Comparables
Compare MimeCure with similar companies based on industry and business-model similarity.
No comparables are published for MimeCure. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
MimeCure Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jan 1, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| VC Round | Nov 1, 2024 | ||||
| Grant | Oct 23, 2024 |
For institutional investors. Book with your work email.
MimeCure Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherlands Organization for Scientific Research | Debt |
| Pharma Connect Capital | VC Round |
| Longfonds | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 617% MoM, from 132 to 947.
- Jan 1, 2026
Secured debt financing from Netherlands Organization for Scientific Research.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardSep 23, 2026
MimeCure BV receives the €10,000 LIFE Science Innovation Award from the LIFE Cooperative at the LIFE Science Conference in Groningen, the Netherlands, on Sep 22nd '26.
For institutional investors. Book with your work email.
MimeCure Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MimeCure's valuation, stock price, and market status.
Is MimeCure a public or private company?
MimeCure is a private company.
What is the current stock price of MimeCure?
MimeCure is a private company, so its shares have no public market price. Caplight tracks MimeCure's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MimeCure worth (valuation)?
Valuation information for MimeCure is not publicly available.
Can I buy MimeCure stock?
MimeCure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MimeCure's last funding round?
MimeCure's most recent funding round was Debt on January 1, 2026.
Who are the main investors in MimeCure?
Key investors in MimeCure include Pharma Connect Capital.
Will MimeCure IPO soon?
No public IPO plans have been announced for MimeCure.
How can I track MimeCure secondary market activity?
Caplight tracks bids, offers, and trades in MimeCure's shares on secondary markets.